Viewing Study NCT03199885


Ignite Creation Date: 2025-12-18 @ 8:36 AM
Ignite Modification Date: 2025-12-23 @ 8:39 PM
Study NCT ID: NCT03199885
Status:
Last Update Posted:
First Post:
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: Testing the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast Cancer
Sponsor:
Organization:

Study Modules

Contacts Locations Module Design Module Eligibility Module Outcomes Module References Module